Compile Data Set for Download or QSAR
Report error Found 1697 Enz. Inhib. hit(s) with Target = 'Poly(ADP-ribose) glycohydrolase'
TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718704(US20250042891, Compound 20)
Affinity DataIC50: 0.0600nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718702(US20250042891, Compound 18)
Affinity DataIC50: 0.120nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718703(US20250042891, Compound 19)
Affinity DataIC50: 0.120nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718710(US20250042891, Compound 26)
Affinity DataIC50: 0.160nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718685(US20250042891, Compound 1)
Affinity DataIC50: 0.200nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718686(US20250042891, Compound 2)
Affinity DataIC50: 0.270nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718689(US20250042891, Compound 5)
Affinity DataIC50: 0.330nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718709(US20250042891, Compound 25)
Affinity DataIC50: 0.340nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616687(US20230278998, Compound 5)
Affinity DataIC50: 0.5nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616699(US20230278998, Compound 17)
Affinity DataIC50: 0.600nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718714(US20250042891, Compound 30)
Affinity DataIC50: 0.610nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616700(US20230278998, Compound 18)
Affinity DataIC50: 0.900nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616727(US20230278998, Compound 46)
Affinity DataIC50: 0.900nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718708(US20250042891, Compound 24)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718706(US20250042891, Compound 22)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718707(US20250042891, Compound 23)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718705(US20250042891, Compound 21)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718767(US20250042891, Compound 85)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718717(US20250042891, Compound 33)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718756(US20250042891, Compound 73)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718690(US20250042891, Compound 6)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718754(US20250042891, Compound 71)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718755(US20250042891, Compound 72)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718752(US20250042891, Compound 69)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718753(US20250042891, Compound 70)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718750(US20250042891, Compound 67)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718751(US20250042891, Compound 68)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718698(US20250042891, Compound 14)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718762(US20250042891, Compound 79)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718699(US20250042891, Compound 15)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718696(US20250042891, Compound 12)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718758(US20250042891, Compound 75)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718695(US20250042891, Compound 11)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718759(US20250042891, Compound 76)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718738(US20250042891, Compound 55)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718739(US20250042891, Compound 56)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718736(US20250042891, Compound 53)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616685(US20230278998, Compound 3)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718747(US20250042891, Compound 64)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718744(US20250042891, Compound 61)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718724(US20250042891, Compound 40)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718722(US20250042891, Compound 38)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718723(US20250042891, Compound 39)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718720(US20250042891, Compound 36)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718721(US20250042891, Compound 37)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718719(US20250042891, Compound 35)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718728(US20250042891, Compound 45)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718729(US20250042891, Compound 46)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718716(US20250042891, Compound 32)
Affinity DataIC50: 1.03nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase [389-976](Human)
Shanghai Yingli Pharmaceutical Co.

US Patent
LigandPNGBDBM718715(US20250042891, Compound 31)
Affinity DataIC50: 1.14nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempartner Chemi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
US Patent

Displayed 1 to 50 (of 1697 total ) | Next | Last >>
Jump to: